Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062191 · ClinicalTrials.gov registry record · NA
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
A NA study, sponsored by ULURU.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01062191 is a NA study that was terminated before completion, run by ULURU. The registered enrollment target is 3 participants.
The verdict
NCT01062191, a NA study, was terminated before completion, sponsored by ULURU.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.
Interventions
- DEVICE Aquacel AG, typical carboxymethylcellulose dressing
- DEVICE Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062191
The ClinicalTrials.gov registry entry for NCT01062191 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ULURU, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aquacel AG, typical carboxymethylcellulose dressing is the first listed.
NCT01062191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062191 about?
NCT01062191 is a clinical study titled "Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl". The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.
What is the current status of trial NCT01062191?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2007-05. Estimated completion is 2008-10.
What interventions are being tested in trial NCT01062191?
The interventions under investigation include: Aquacel AG, typical carboxymethylcellulose dressing (DEVICE), Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing (DEVICE).
Who is sponsoring clinical trial NCT01062191?
This trial is sponsored by ULURU, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.